0001179110-20-003203.txt : 20200305
0001179110-20-003203.hdr.sgml : 20200305
20200305204300
ACCESSION NUMBER: 0001179110-20-003203
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20200304
FILED AS OF DATE: 20200305
DATE AS OF CHANGE: 20200305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smiley Andrea Heslin
CENTRAL INDEX KEY: 0001703767
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36295
FILM NUMBER: 20692432
MAIL ADDRESS:
STREET 1: 600 LEE ROAD, SUITE 100
CITY: WAYNE
STATE: PA
ZIP: 19087
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zyla Life Sciences
CENTRAL INDEX KEY: 0001586105
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 463575334
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 600 LEE ROAD
STREET 2: SUITE 100
CITY: WAYNE
STATE: PA
ZIP: 19087
BUSINESS PHONE: 610-833-4200
MAIL ADDRESS:
STREET 1: 600 LEE ROAD
STREET 2: SUITE 100
CITY: WAYNE
STATE: PA
ZIP: 19087
FORMER COMPANY:
FORMER CONFORMED NAME: Egalet Corp
DATE OF NAME CHANGE: 20130906
4
1
edgar.xml
FORM 4 -
X0306
4
2020-03-04
0
0001586105
Zyla Life Sciences
ZCOR
0001703767
Smiley Andrea Heslin
600 LEE ROAD, SUITE 100
WAYNE
PA
19087
1
0
0
0
Common Stock
2020-03-04
4
A
0
13620
0
A
13620
D
Represents restricted stock units, which vest the day prior to the Company's annual meeting of stockholders to be held in 2021.
/s/ Megan Timmins, attorney-in-fact for Andrea Heslin Smiley
2020-03-05
EX-24
2
ex24ahsmiley.txt
LIMITED POWER OF ATTORNEY FOR SECTION 16 REPORTING
OBLIGATIONS
Know all by these presents, that the undersigned
hereby makes, constitutes and appoints Todd Smith,
Megan Timmins and Jesse Neri as the undersigned's
true and lawful attorney-in-fact, with full power and
authority as hereinafter described on behalf of and in
the name, place and stead of the undersigned to:
(1) prepare, execute, acknowledge, deliver and
file (i) Forms 3, 4, and 5 (as applicable, including
any amendments thereto) with respect to the securities
of Zyla Life Sciences, a Delaware corporation (the
"Company"), with the United States Securities and
Exchange Commission, any national securities exchanges
and the Company, as considered necessary or advisable
under Section 16(a) of the Securities Exchange Act of
1934 and the rules and regulations promulgated
thereunder, as amended from time to time (the
"Exchange Act") and (ii) such forms as may be required
in connection with any applications for EDGAR access
codes, including, without limitation, the Form ID;
(2) seek or obtain, as the undersigned's
representative and on the undersigned's behalf,
information on transactions in the Company's
securities from any third party, including but not
limited to brokers, employee benefit plan
administrators and trustees, and the undersigned
hereby authorizes any such third party to release any
such information to the undersigned and approves and
ratifies any such release of information to the
undersigned; and
(3) perform any and all other acts which in the
discretion of such attorney-in-fact are necessary or
desirable for and on behalf of the undersigned in
connection with the foregoing.
The undersigned acknowledges that:
(1) this Limited Power of Attorney authorizes, but
does not require, such attorney-in-fact to act in his
or her discretion on information provided to such
attorney-in-fact without independent verification of
such information;
(2) any documents prepared and/or executed by such
attorney-in-fact on behalf of the undersigned pursuant
to this Limited Power of Attorney will be in such form
and will contain such information and disclosure as
such attorney-in-fact, in his or her discretion, deems
necessary or desirable;
(3) neither the Company nor such attorney-in-fact
assumes (i) any liability for the undersigned's
responsibility to comply with the requirements of the
Exchange Act, (ii) any liability of the undersigned
for any failure to comply with such requirements, or
(iii) any obligation or liability of the undersigned
for profit disgorgement under Section 16(b) of the
Exchange Act; and
(4) this Limited Power of Attorney does not
relieve the undersigned from responsibility for
compliance with the undersigned's obligations under
the Exchange Act, including without limitation the
reporting requirements under Section 16 of the
Exchange Act.
The undersigned hereby gives and grants the foregoing
attorney-in-fact full power and authority to do and
perform all and every act and thing whatsoever
requisite, necessary or appropriate to be done in and
about the foregoing matters as fully to all intents
and purposes as the undersigned might or could do if
present, hereby ratifying all that such attorney-in-
fact of, for and on behalf of the undersigned, shall
lawfully do or cause to be done by virtue of this
Limited Power of Attorney.
This Limited Power of Attorney shall remain in full
force and effect until revoked by the undersigned in a
signed writing delivered to such attorney-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this
Limited Power of Attorney to be executed as of this
23rd day of October, 2019.
/s/ Andrea Heslin Smiley
Name: Andrea Heslin Smiley